Bob Nelsen is one of the most colorful and audacious characters in biotech investing. Nelsen co-founded and manages ARCH Venture Partners, one of the largest VC firms devoted to biotech investing, where he has pushed forward a series of companies aimed at addressing his frustrations with the health care sector. He’s not looking to quickly flip startups into pharma acquisitions or please the market — a rarity in the VC ecosystem. “We don’t really care what the market thinks. … And we don’t really care what pharma thinks, either,” he said last September, while discussing ARCH’s new $3 billion investment fund. “We’re valuable to pharma because we think orthogonally to them.”
From STAT:
ARCH Venture Partners raises $3 billion for a new biotech fund
Industry
Location
-
Rocky Mountains
